Nrf2 as a potential target for the treatment of epilepsy

Nrf2 as a potential target for the treatment of epilepsy

Bibliographic Details
Main Authors:	Prince Kumar Singh, Tawfeeq Shekh-Ahmad
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-01-01
Series:	Neural Regeneration Research
Online Access:	http://www.nrronline.org/article.asp?issn=1673-5374;year=2024;volume=19;issue=9;spage=1865;epage=1866;aulast=

Similar Items

Nrf2 is predominantly expressed in hippocampal neurons in a rat model of temporal lobe epilepsy
by: Sereen Sandouka, et al.
Published: (2023-01-01)

Induction of the Nrf2 Pathway by Sulforaphane Is Neuroprotective in a Rat Temporal Lobe Epilepsy Model
by: Sereen Sandouka, et al.
Published: (2021-10-01)

Specific inhibition of NADPH oxidase 2 modifies chronic epilepsy
by: Prince Kumar Singh, et al.
Published: (2022-12-01)

Repurposing dimethyl fumarate as an antiepileptogenic and disease-modifying treatment for drug-resistant epilepsy
by: Sereen Sandouka, et al.
Published: (2023-11-01)

Approaches for Reactive Oxygen Species and Oxidative Stress Quantification in Epilepsy
by: Rhoda Olowe, et al.
Published: (2020-10-01)

The Dual Role of NRF2 in Colorectal Cancer: Targeting NRF2 as a Potential Therapeutic Approach
by: Hu M, et al.
Published: (2024-09-01)

The untapped potential of targeting NRF2 in neurodegenerative disease
by: Wei-Tai Chen, et al.
Published: (2023-09-01)

Targeting Nrf2 with Probiotics and Postbiotics in the Treatment of Periodontitis
by: Basar Karaca, et al.
Published: (2022-05-01)

Targeting Nrf2 for the treatment of Duchenne Muscular Dystrophy
by: Stephanie Kourakis, et al.
Published: (2021-01-01)

NRF2 ACTIVATION AS TARGET TO IMPLEMENT THERAPEUTIC TREATMENTS
by: Velio eBocci, et al.
Published: (2015-02-01)

Nrf2 as a Potential Therapeutic Target for Traumatic Brain Injury
by: P. M. Abdul-Muneer
Published: (2023-06-01)

The Nrf2 System as a Potential Target for the Development of Indirect Antioxidants
by: Mi-Kyoung Kwak, et al.
Published: (2010-10-01)

Therapeutic potential of targeting Nrf2 by panobinostat in pituitary neuroendocrine tumors
by: Yijun Cheng, et al.
Published: (2024-04-01)

The Potential of Nrf2 Activation as a Therapeutic Target in Systemic Lupus Erythematosus
by: Michelle T. Barati, et al.
Published: (2022-02-01)

Research progress of targeting on Nrf2/ARE pathway in the treatment of ischemic stroke
by: YANG Xiaofei, LI Qiang, LI Yanfeng, WANG Hongquan
Published: (2023-01-01)

Role of STAT3 and NRF2 in Tumors: Potential Targets for Antitumor Therapy
by: Yanjun Tian, et al.
Published: (2022-12-01)

Defining the Functional Targets of Cap‘n’collar Transcription Factors NRF1, NRF2, and NRF3
by: Lara Ibrahim, et al.
Published: (2020-10-01)

Unleashing the Potential of Nrf2: A Novel Therapeutic Target for Pulmonary Vascular Remodeling
by: Qin Fang, et al.
Published: (2023-11-01)

Are vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy?
by: Joeri eVan Liefferinge, et al.
Published: (2013-08-01)

Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-κB pathways in diabetic neuropathy
by: Veera Ganesh Yerra, et al.
Published: (2013-01-01)

Keap1 cysteine 288 as a potential target for diallyl trisulfide-induced Nrf2 activation.
by: Sanghyun Kim, et al.
Published: (2014-01-01)

Targeting Nrf2 signaling in dry eye
by: Yu-Nuo Zhang, et al.
Published: (2024-10-01)

Potential Benefits of Nrf2/Keap1 Targeting in Pancreatic Islet Cell Transplantation
by: Alberto Jarrin Lopez, et al.
Published: (2020-04-01)

Marburgvirus Hijacks Nrf2-Dependent Pathway by Targeting Nrf2-Negative Regulator Keap1
by: Audrey Page, et al.
Published: (2014-03-01)

NRF2 as a Therapeutic Target in Neurodegenerative Diseases
by: Mikah S. Brandes, et al.
Published: (2020-01-01)

KEAP1/NRF2 as a druggable target
by: Dinkova-Kostova Albena T.
Published: (2023-01-01)

Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma
by: Marie Angèle Cucci, et al.
Published: (2023-06-01)

Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease.
by: Fiona Kerr, et al.
Published: (2017-03-01)

NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases
by: Ángel Cores, et al.
Published: (2020-06-01)

Astrocyte mitochondria: Potential therapeutic targets for epilepsy
by: Lu Chen, et al.
Published: (2024-05-01)

Targeting Nrf2 Signaling Pathway in Cancer Prevention and Treatment: The Role of Cannabis Compounds
by: Anna Rybarczyk, et al.
Published: (2023-11-01)

Triptolide Downregulates the Expression of NRF2 Target Genes by Increasing Cytoplasmic Localization of NRF2 in A549 Cells
by: Le Ba Nam, et al.
Published: (2021-09-01)

Targeting the Interplay Between Autophagy and the Nrf2 Pathway in Parkinson’s Disease with Potential Therapeutic Implications
by: Mengru Liu, et al.
Published: (2025-01-01)

Nrf2/ARE Signaling Pathway: Key Mediator in Oxidative Stress and Potential Therapeutic Target in ALS
by: Susanne Petri, et al.
Published: (2012-01-01)

Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers
by: Li Lin, et al.
Published: (2023-09-01)

Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer
by: Pelin Telkoparan-Akillilar, et al.
Published: (2021-03-01)

NFE2L1/Nrf1 serves as a potential therapeutical target for neurodegenerative diseases
by: Kamila Łuczyńska, et al.
Published: (2024-02-01)

The Nrf2/ARE pathway as a potential target to ameliorate atrazine-induced endocrine disruption in granulosa cells
by: Xiao-Wei Li, et al.
Published: (2024-06-01)

Inflammasomes in Alzheimer’s Progression: Nrf2 as a Preventive Target
by: Rubén López-Hernández, et al.
Published: (2025-01-01)

Serotonin receptors in epilepsy: Novel treatment targets?
by: Jo Sourbron, et al.
Published: (2022-06-01)